MIRA INFORM REPORT

Report Date :

02.06.2011

IDENTIFICATION DETAILS

Name :	HEALTH CARE PRODUCTS

Registered Office :	237-A, Block-2, P.E.C.H.S., Shahrah-e-Quaideen, Karachi

Country :	Pakistan

Year of Establishment :	1995

Legal Form :	Partnership

Line of Business :	Import, Indenting & Trading of Pharmaceutical Machineries & Equipments, Pharmaceutical Raw Materials etc

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Status :	Satisfactory

Payment Behaviour :	No Complaints

Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2011

Country Name

Previous Rating

(31.12.2010)

Current Rating

(31.03.2011)

Pakistan

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Bottom of Form

Business Name

HEALTH CARE PRODUCTS

Full Address

Registered Address

237-A, Block-2, P.E.C.H.S., Shahrah-e-Quaideen, Karachi, Pakistan

Tel #	92 (21) 34537254, 34525475
Fax #	92 (21) 34520739
Email	seco@cyber.net.pk

Short Description Of Business

a.	Nature of Business	Import, Indenting & Trading of Pharmaceutical Machineries & Equipments, Pharmaceutical Raw Materials etc
b.	Year Established	1995
c.	National Tax No.	0299130

Branches

In Islamabad, Lahore, Karachi & Multan

Legal Status

Subject Concern was established as a Partnership business in 1995

Details of Managing Partner / Partners

Names

Nationality

Address

Occupation

Designation

Mr. Waseem Ferozuddin

Mr. Ayaz Ferozuddin

Mr. Nazimuddin Ferozuddin

Pakistani

237-A, Block-2, P.E.C.H.S., Shahrah-e-Quaideen, Karachi

Business

Managing Partner

Partner

Associates

A. Subsidiary

None

B. Associated Companies

(1) Hospital Supply Corporation, Pakistan.

(2) Otsuka Pakistan Limited, Pakistan.

(3) Efroze Pharmaceuticals Limited, Pakistan.

(4) Uniferoz, Pakistan.

(5) May Marketing Enterprises, Pakistan.

(6) S. S. Medico, Pakistan.

(7) Multitech Marketing Services, Pakistan.

(8) Efroze Chemical Industries (Pvt) Limited, Pakistan.

(9) S. Ejazuddin & Co., Pakistan.

Business Activities

Import, Indenting & Trading of Pharmaceutical Machineries & Equipments, Pharmaceutical Raw Materials etc

Number of Employees

Annual Sales Volume

Year	In Pak Rupees
2009	100,000,000/- (Estimated)

Agencies

(Foreign)

Mainly Jordan of Norway, 3M of USA, Valdi of Poland, Cecedille of France, Cosmopolitan of Germany, Binney and Smith of England

Customers

Mainly Distributors, Trading Companies, Pharmacies, Retailers etc

Bankers

· Habib Bank Limited, Pakistan.

· MCB Bank Limited, Pakistan.

· Allied Bank Limited, Pakistan.

· Bank Alfalah Limited, Pakistan.

· United Bank Limited, Pakistan.

Memberships

· Karachi Chamber of Commerce & Industry.(KCCI)

Foreign Exchange Rates

Currency	Unit	Pakistani Rupees
US Dollar	1	Rs. 86.05
UK Pound	1	Rs. 141.00
Euro	1	Rs. 123.40

Comments

Subject Concern was established in 1995 and is engaged in import, indenting & trading of Pharmaceutical Machineries & Equipments, Pharmaceutical Raw Materials etc. Trade relations are reported as fair. Payments to creditors are reported as normal. Subject can be considered for normal business dealings at usual trade terms and conditions.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.44.89
UK Pound	1	Rs.73.85
Euro	1	Rs.64.76

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.